| 06/16 | SAGE THERAPEUTICS : and Biogen Announce Positive Pivotal Phase 3 Results for Zu.. | AQ |
| 06/15 | Cracker Barrel, Sage Therapeutics fall; Ocugen, FedEx rise | AQ |
| 06/15 | SAGE THERAPEUTICS : to Host Conference Call | BU |
| 06/15 | SAGE THERAPEUTICS : and Biogen Announce Positive Pivotal Phase 3 Results for Zu.. | PU |
| 06/15 | SAGE THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (form.. | AQ |
| 06/10 | SAGE THERAPEUTICS, INC. : Submission of Matters to a Vote of Security Holders (.. | AQ |
| 05/20 | SAGE THERAPEUTICS : Joins MTV Entertainment Group and More Than 1,300 Leading O.. | BU |
| 05/13 | SAGE THERAPEUTICS TO HOST SAGE SCIEN : SAGE-718 In Depth | BU |
| 05/04 | SAGE THERAPEUTICS : Company on-track to initiate placebo-controlled Phase 2 tri.. | PU |
| 05/04 | SAGE THERAPEUTICS : Management's Discussion and Analysis of Financial Condition.. | AQ |
| 05/04 | SAGE THERAPEUTICS, INC. : Results of Operations and Financial Condition, Financ.. | AQ |
| 05/04 | SAGE THERAPEUTICS : Announces First Quarter 2021 Financial Results and Highligh.. | BU |
| 04/28 | SAGE THERAPEUTICS : to Present at Upcoming May Investor Conferences | BU |
| 04/20 | SAGE THERAPEUTICS : to Report First Quarter 2021 Financial Results on Tuesday, .. | BU |
| 04/12 | SAGE THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (form.. | AQ |
| 03/24 | SAGE THERAPEUTICS : to Present at the Stifel 3rd Annual CNS Day | BU |
| 03/18 | SAGE THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (form.. | AQ |
| 03/17 | SAGE THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K) | AQ |
| 03/17 | SAGE THERAPEUTICS : Announces Continued Positive Zuranolone Data for Both 30 mg.. | BU |
| 03/16 | SAGE THERAPEUTICS : Announces Departure of Chief Operating Officer | BU |
| 02/24 | SAGE THERAPEUTICS : Management's Discussion and Analysis of Financial Condition.. | AQ |
| 02/24 | SAGE THERAPEUTICS, INC. : Results of Operations and Financial Condition, Financ.. | AQ |
| 02/24 | SAGE THERAPEUTICS : Announces Fourth Quarter and Full Year 2020 Financial Resul.. | BU |
| 02/11 | SAGE THERAPEUTICS : to Present at Upcoming Investor Conferences | BU |
| 02/10 | SAGE THERAPEUTICS : to Report Fourth Quarter and Full Year 2020 Financial Resul.. | BU |
| 01/07 | SAGE THERAPEUTICS, INC. : Results of Operations and Financial Condition, Other .. | AQ |
| 01/07 | SAGE THERAPEUTICS : Provides 2021 Corporate Strategy Update at J.P. Morgan Heal.. | BU |
| 2020 | SAGE THERAPEUTICS, INC. : Other Events (form 8-K) | AQ |
| 2020 | SAGE THERAPEUTICS : to Present at the 39th Annual J.P. Morgan Healthcare Confer.. | BU |
| 2020 | SAGE THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K) | AQ |
| 2020 | SAGE THERAPEUTICS : Announces the Appointment of Barry Greene as CEO | BU |
| 2020 | SAGE THERAPEUTICS : to Present at BMO 2020 Growth and ESG Conference | AQ |
| 2020 | SAGE THERAPEUTICS : to Present at BMO 2020 Growth & ESG Conference | BU |
| 2020 | BIOGEN : and Sage Therapeutics Announce Global Collaboration to Develop and Com.. | AQ |
| 2020 | SAGE THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Unregiste.. | AQ |
| 2020 | BIOGEN : and Sage Therapeutics Announce Global Collaboration to Develop and Com.. | AQ |
| 2020 | SAGE THERAPEUTICS : Management's Discussion and Analysis of Financial Condition.. | AQ |
| 2020 | SAGE THERAPEUTICS, INC. : Results of Operations and Financial Condition, Financ.. | AQ |
| 2020 | SAGE THERAPEUTICS : Announces Third Quarter 2020 Financial Results and Highligh.. | BU |
| 2020 | SAGE THERAPEUTICS : to Present at Upcoming November Investor Conferences | AQ |
| 2020 | SAGE THERAPEUTICS : to Present at Upcoming November Investor Conferences | BU |
| 2020 | SAGE THERAPEUTICS : Announces Chief Executive Jeff Jonas to Undergo Scheduled M.. | AQ |
| 2020 | SAGE THERAPEUTICS : Announces Chief Executive Jeff Jonas to Undergo Scheduled M.. | BU |
| 2020 | SAGE THERAPEUTICS : to Report Third Quarter 2020 Financial Results on Thursday,.. | AQ |
| 2020 | SAGE THERAPEUTICS : to Report Third Quarter 2020 Financial Results on Thursday,.. | BU |
| 2020 | SAGE THERAPEUTICS : Announces Positive Interim, Topline Zuranolone Safety and T.. | AQ |
| 2020 | SAGE THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (form.. | AQ |
| 2020 | SAGE THERAPEUTICS : Announces Positive Interim, Topline Zuranolone Safety and T.. | BU |
| 2020 | SAGE THERAPEUTICS : Appoints Barry Greene to Board of Directors | AQ |
| 2020 | SAGE THERAPEUTICS, INC. : Change in Directors or Principal Officers, Other Even.. | AQ |
| 2020 | SAGE THERAPEUTICS : Appoints Barry Greene to Board of Directors | BU |
| 2020 | SAGE THERAPEUTICS : rsquo; FutureCast to Provide Update on Pipeline Progression.. | BU |
| 2020 | SAGE THERAPEUTICS : to Present at Morgan Stanley 18th Annual Global Healthcare .. | BU |
| 2020 | SAGE THERAPEUTICS : to Host Sage FutureCast Webcast | BU |
| 2020 | SAGE THERAPEUTICS : Management's Discussion and Analysis of Financial Condition.. | AQ |
| 2020 | SAGE THERAPEUTICS, INC. : Results of Operations and Financial Condition, Financ.. | AQ |
| 2020 | SAGE THERAPEUTICS : Announces Second Quarter 2020 Financial Results and Highlig.. | BU |
| 2020 | SAGE THERAPEUTICS : to Present at 2020 Wedbush PacGrow Healthcare Virtual Confe.. | BU |
| 2020 | SAGE THERAPEUTICS : to Report Second Quarter 2020 Financial Results on Monday, .. | BU |
| 2020 | SAGE THERAPEUTICS, INC. : Submission of Matters to a Vote of Security Holders (.. | AQ |
| 2020 | SAGE THERAPEUTICS : to Present at Goldman Sachs 41st Annual Global Healthcare C.. | BU |
| 2020 | SAGE THERAPEUTICS : to Present at Bank of America Health Care Conference 2020 | AQ |
| 2020 | SAGE THERAPEUTICS : to Present at Bank of America Health Care Conference 2020 | BU |
| 2020 | SAGE THERAPEUTICS, INC. : Results of Operations and Financial Condition, Change.. | AQ |
| 2020 | SAGE THERAPEUTICS : Management's Discussion and Analysis of Financial Condition.. | AQ |
| 2020 | SAGE THERAPEUTICS : Announces First Quarter 2020 Financial Results and Highligh.. | BU |
| 2020 | SAGE THERAPEUTICS : to Report First Quarter 2020 Financial Results on Thursday,.. | BU |
| 2020 | SAGE THERAPEUTICS, INC. : Costs Associated with Exit or Disposal Activities, Ot.. | AQ |
| 2020 | SAGE THERAPEUTICS : Announces Restructuring to Advance Corporate Strategy and P.. | BU |
| 2020 | SAGE THERAPEUTICS : Announces Inducement Grants Under NASDAQ Listing Rule 5635(.. | AQ |
| 2020 | SAGE THERAPEUTICS : Announces Inducement Grants Under NASDAQ Listing Rule 5635(.. | BU |
| 2020 | SAGE THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (form.. | AQ |
| 2020 | SAGE THERAPEUTICS : Announces Development Plan for Zuranolone (SAGE-217) Follow.. | BU |
| 2020 | SAGE THERAPEUTICS : Announces Inducement Grants Under NASDAQ Listing Rule 5635(.. | BU |
| 2020 | SAGE THERAPEUTICS : SEC Filing (S-8) | PU |
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
